Universal Biotech Innovation Grant

Universal Biotech is promoting the Innovation Grant, a major event in the European biotechnologies scene.

The Universal Biotech Innovation Grant is aiming to:

• acknoweldge innovative talent and the development of new processes or products in the biotechnology industries sector
• allow those pro-active in the French and European biotechnology industries to be brought together around a common objective – excellence in the technical innovation and the development of bio-industries.

Feedback on the 2009 edition success

Thanks to the active participation of jury members and to the support of industrial partners, the 2009 edition was a real success.

Universal Biotech thanks gratefully its partners:

- French Ministry of Research

- Industrial partners: Merck Sharp & Dohme-Chibret, Sanofi-Aventis,

- Institutional partners: European Commission, Adebiotech, National Agency for Research, CEA, Eurasanté, Eurobio 2009, Genopôle, Ifremer, Inserm, and Medicen Paris Region.

The 2009 Innovation Grant was awarded to NETRIS-Pharma.

This company has worked with the UMR 5238 CNRS Unit and is dedicated to the discovery and the development of new targeted therapies in oncology, based on the concept of dependence receptors. NETRIS-Pharma currently develops anti-cancer molecules for the treatment of the metastatic breast cancer, the lung cancer and certain paediatric cancers.

Principles

The Universal Biotech Innovation Grant is based around three objectives:

• Innovation – a degree of innovation or ingenuity shown in the reflexes and experimentation necessary to discover, to create or to conceive new applications in the biotechnology industry, and degree of originality and of the conception or style used to realise the invention

• Strategy – commercialisation plan, position on the market, maturity of the product / technology

• Industrial property

2010 Themes

The emphasis of the 2010 Universal Biotech Innovation Grant will be placed on therapeutic innovation.

Applications must be entered under one of the two following thematic areas:

• Innovative therapies
  

• Diagnostic products
  

A Grant up to 100 000 euros will be shared by two or three winners.

These grants will be awarded after a selection process and a critical evaluation of the candidates applications by an expert jury.

Universal Biotech will assist the winners through their development with certain special privileges and assistance.

Download the Universal Biotech Innovation Grant Brochure

> How to apply?